[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Polio vac for all London children", "description": "Poliomyelitis, London, New York and Israel\n\nAll children aged 1 to 9 in London to be offered a dose of polio vaccine\n\nLast UK case, 1984\n\n8,000 people developed paralysis every year\n\nhttps://www.gov.uk/government/organisations/uk-health-security-agency\n\nhttps://www.gov.uk/government/news/all-children-aged-1-to-9-in-london-to-be-offered-a-dose-of-polio-vaccine\n\nVaccine-derived poliovirus in sewage in north and east London\n\nGenetic diversity (RNA virus)\n\nMost are vaccine-like virus\n\nA few have sufficient mutations to be classified as vaccine derived poliovirus (VDPV2),\n\nbehaves more like naturally occurring \u2018wild\u2019 polio\n\nJoint Committee on Vaccination and Immunisation (JCVI)\n\nTargeted inactivated polio vaccine (IPV) booster dose,\n\noffered to all children between the ages of 1 and 9 in all London boroughs\n\nThis will ensure a high level of protection from paralysis and help reduce further spread of the virus.\n\nThe programme will start with the areas affected, \n\nwhere the poliovirus has been detected and vaccination rates are low\n\nIt\u2019s important all children aged 1 to 9 \u2013 even if up to date with their vaccinations \u2013 accept this vaccine when offered\n\nBeckton sewage treatment works first\n\nNow also,\n\nBarnet, Brent, Camden, Enfield, Hackney, Haringey, Islington, Waltham Forest\n\nA total of 116 PV2 isolates identified in 19 sewage samples\n\n\nPoliomyelitis\n\nhttps://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/148141/Green-Book-Chapter-26-Polio-updated-18-January-2013.pdf\n\nhttps://www.cdc.gov/vaccines/vpd/polio/public/index.html\n\nAn acute illness\n\nFollows invasion through the gastro intestinal tract by polio virus\n\nVirus replicates in the gut\n\nHas a high affinity for nervous tissue\n\nSpread occurs via the bloodstream\n\nRetrograde axonal transport to the central nervous system\n\nOften infection is clinically inapparent\n\nSymptoms may range in severity\n\nFever to \n\nHeadache, \n\nGastrointestinal disturbance, \n\nMalaise\n\nStiffness of the neck and back\n\nAseptic meningitis\n\nParalysis.\n\nRatio of inapparent to paralytic infections\n\n1000 to 1 in children\n\n75 to 1 in adults\n\nTransmission\n\nContact with the faeces or pharyngeal secretions\n\nPolio virus replicates long periods in GI tract\n\nCan be excreted for three to six weeks in faeces\n\nCan be excreted for two weeks in saliva\n\nIncubation period\n\nThree to 21 days\n\nWhen the infection was endemic\n\nParalytic disease is caused by naturally occurring \u2018wild virus\u2019\n\nLive attenuated vaccine, (OPV \u2013 Sabin) \nVirus retains the potential to revert to a virulent form,\n\nthat can rarely cause paralytic disease\n\nVaccine-associated paralytic polio (VAPP)\n\nVAPP cases can occur rarely where live attenuated vaccines are used\n\nOPV not used in UK since 2004\n\n(US, not since 2000)\n\nInactivated polio vaccine (i.m. injected) for routine immunisation\n\ntetanus/diphtheria/inactivated polio vaccine\n\ndiphtheria/tetanus/pertussis/inactivated polio vaccine \n\nRecommended at two, three and four months of age,\n\ncan be given at any stage from two months up to ten years of age", "link": "https://www.youtube.com/watch?v=5nbnFrOzd0g", "date_published": "2022-08-10 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]